TABLE 3.

Correlation between therapeutic effects and changes in tumors TIC values before and at 4 weeks after lenvatinib administration

Therapeutic effect	Decrease (n = 14)	Increase (n = 5)	p‐value
CR	1 (5%)	0 (0%)
PR	10 (53%)	0 (0%)
SD	3 (16%)	2 (11%)
PD	0 (0%)	3 (16%)	.0051
Response (CR + PR)	11 (58%)	0 (0%)	.0023
Disease control (CR + PR + SD)	14 (74%)	2 (11%)	.0016

Abbreviations: CR, complete response; PD, progressive disease; PR, partial response; SD, stable disease; TIC, time‐intensity curve.